Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department
Open Access
- 1 February 2015
- journal article
- research article
- Vol. 7 (1) , S12-S19-S19
Abstract
Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary DepartmentKeywords
This publication has 26 references indexed in Scilit:
- The Cost of Treating Advanced Non-Small Cell Lung Cancer: Estimates from the Chinese ExperiencePLOS ONE, 2012
- Metastatic non-small cell lung cancer: costs associated with disease progression.2008
- Tobacco use in the European regionEuropean Journal Of Cancer Prevention, 2008
- Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599Journal of Clinical Oncology, 2008
- Factors influencing hospital costs of lung cancer patients in Northern IrelandThe European Journal of Health Economics, 2007
- Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000Journal of Clinical Oncology, 2004
- Management and Costs of Treating Lung Cancer Patients in a University HospitalPharmacoEconomics, 2004
- Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in FrancePharmacoEconomics, 2003
- Treatment pathways, resource use and costs in the management of small cell lung cancerThorax, 2001
- Quality of Life in Patients With Lung CancerChest, 1998